SEC Requires Activist Investors to Disclose Client Identities in Filings

The U.S. Securities and Exchange Commission (SEC) has issued new guidance requiring activist investors to disclose the identities of their clients, a significant move toward greater transparency that could disrupt hedge fund strategies. The unexpected update clarifies the regulator's interpretation of disclosure rules for investors pushing for changes at public companies.

New Disclosure Mandates

In an update to its Corporate Finance Interpretations published Thursday, the SEC specified new requirements for 13D filings and proxy statements. The guidance now makes it clear that the identities of investors in an entity created specifically for an activist campaign must be disclosed.

According to the SEC's interpretation, clients are considered "participants" in a proxy solicitation if they have invested more than $500 in a limited partnership involved in the campaign. This clarification directly targets the secrecy that activist funds have historically maintained around their financial backers.

Impact on Activist Funds and SPVs

The new interpretation is likely to rattle activist hedge funds, which have long argued that the confidentiality of their investors, or limited partners, is crucial for protecting their strategies and preventing copycats. The guidance takes aim at the increasing use of special purpose vehicles (SPVs), often called "sidecars," which are formed to raise capital from clients for a single, targeted activist campaign.

Ad

While hedge funds have prized this secrecy, targeted corporations have argued that knowing the identity of an activist's backers is necessary to mount an effective defense. This SEC guidance shifts the balance by providing companies with more information about who is financing a challenge to their board or strategy.

Broader Context and Precedent

The SEC's move follows a busy first half of 2026 for shareholder activism, with firms like Elliott Investment Management and Ancora Alternatives launching campaigns at companies such as Warner Bros Discovery and Devon Energy. The new guidance echoes a contentious 2022 event when medical device firm Masimo Corp. amended its bylaws to force activist Politan Capital to disclose its investors.

The Masimo bylaw sparked an outcry among investors and was reversed in early 2023. However, the SEC's action establishes a regulatory expectation for this level of disclosure, carrying more weight than a single company's policy and signaling a broader push for transparency in the market.